Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities

Cell Growth and Differentiation

Volumn 13, Issue 6, 2002, Pages 247-256

  Penington, Desi J ^a   Bryant, Ianthe ^a   Riese II, David J ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; MUTANT PROTEIN; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR; PRIMER DNA; TYROSINE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CONTACT INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; CELL ADHESION; CELL CULTURE; CELL DIVISION; CHEMISTRY; CLONOGENIC ASSAY; FIBROBLAST; GENETICS; HUMAN; IMMUNOBLOTTING; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PLASMID; POLYMERASE CHAIN REACTION; RETROVIRUS; SIGNAL TRANSDUCTION;

CELL ADHESION; CELL DIVISION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CONTACT INHIBITION; DNA PRIMERS; FIBROBLASTS; HUMAN; IMMUNOBLOTTING; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PLASMIDS; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RETROVIRIDAE; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TYROSINE; HUMANS;

ANIMALIA; RODENTIA;

EID: 0035989898     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
2. Requirement for neuregulin receptor ErbB2 in neuronal and cardiac development
3. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor
4. Aberrant neuronal and cardiac development in mice lacking the ErbB4 neuregulin receptor
5. Structural alterations of the epidermal growth factor receptor gene in human gliomas
6. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors
7. Expression of EGF, TGF-α, and EGFR in squamous cell lung carcinoma
8. The biology of ErbB-2/Neu/HER-2 and its role in cancer
9. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors
10. Expression of the c-ErbB-3 gene product in gastric cancer
11. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas
12. c-ErbB-4 protein expression in human breast cancer
13. Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa
14. Expression of the ErbB-2 family of growth factor receptors and their ligands in breast cancer: Implications for tumor biology and clinical behavior
15. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
16. c-ErbB3 and c-ErbB4 expression is a feature of the endocrine responsive phenotype in clinical cancer
17. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors
18. HER-2/neu amplification predicts poor survival in node-positive breast cancer
19. Expression of the c-erbB4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumor types
20. Betacellulin activates the epidermal growth factor receptor and erbB-4 and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-β
21. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2
22. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
23. Specificity within the EGF family/ErbB receptor family signaling network
24. EGF-stimulated tyrosine phosphorylation of p185neu: A potential model for receptor interactions
25. The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4
26. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family
27. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain
28. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface
29. Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I
30. Constitutive receptor activation by Crouzon syndrome mutations in fibroblasts growth factor receptor (FGFR) 2 and FGFR2/Neu chimeras
31. HER4 mediated biological and biochemical properties in NIH 3T3 cells
32. The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells
33. Transformation of NIH3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2*
34. neu/erbB2 in a subset of human breast tumors overexpressing this receptor
35. Isolation of the Neu/HER-2 stimulatory ligand: A 44 Kd glycoprotein that induces differentiation of mammary tumor cells
36. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli
37. HER4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells
38. Distinct tyrosine autophosphorylation sites negatively and positively modulate Neu-mediated transformation
39. Ligand-independent activation of the platelet-derived growth factor β receptor: Requirements for bovine papillomavirus E5-induced mitogenic signaling
40. Ligand discrimination in signaling through an ErbB4 receptor homodimer
41. Improved retroviral vectors for gene transfer and expression
42. Transformation of mortal human fibroblasts and activation of a growth inhibitory pathway by the bovine papillomavirus E5 oncoprotein
43. Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type I and human papillomavirus type 16
44. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein
45. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus
46. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
47. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding
48. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein
49. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene